This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Unaudited consolidated September 2026 quarter: revenue up 58%, PAT up 135% year on year
JAYAGROGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended September 30, 2026: revenue from operations rose 57.6% to Rs 78,734.59 lakh from Rs 49,959.65 lakh, while PAT rose 134.7% to Rs 2,162.09 lakh from Rs 921.24 lakh a year earlier. EBITDA margin rose by 1.04 percentage points to 5.5%. Consolidated half-year: revenue Rs 1,58,395.33 lakh, PAT Rs 4,224.83 lakh, operating cash flow negative Rs 25,932.40 lakh. Standalone quarter: revenue Rs 37,688.24 lakh, PAT Rs 2,068.81 lakh.
Strong sales and profit growth supports sentiment, but negative operating cash flow and sharply higher borrowings may weigh on the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹787.3 Cr | ₹499.6 Cr | +57.6% |
| Operating profit | ₹29.53 Cr | ₹12.60 Cr | +134.4% |
| Profit after tax | ₹21.62 Cr | ₹9.21 Cr | +134.7% |
| EBITDA margin | 5.5% | 4.5% | +1.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.